21.05.2024 - 23.05.2024Omni Parker House, 60 School St, 02108 Boston, Massachusetts, USA
Time: 9:00 AM - 2:00 PM
Conference themes The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more